deoxypyridinoline has been researched along with menaquinone 6 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, C; Miura, M; Shiraki, M; Shiraki, Y | 1 |
| Ezawa, I; Fukagawa, M; Iwasaki, Y; Kurokawa, K; Murayama, H; Sato, M; Takahashi, T; Yamato, H | 2 |
| Hirai, H; Nakajima, S; Nishimura, K; Okada, S; Shima, M; Shimizu, N; Yamaoka, K | 1 |
| Aisaka, K | 1 |
| Ikeda, S; Ito, M; Nakamura, T; Otomo, H; Phipps, RJ; Sakai, A; Tanaka, S | 1 |
| Irahara, M; Miura, M; Miyatani, Y; Tomita, J; Uemura, H; Yamada, M; Yasui, T | 1 |
3 trial(s) available for deoxypyridinoline and menaquinone 6
| Article | Year |
|---|---|
Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.
Topics: Absorptiometry, Photon; Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Female; Fractures, Spontaneous; Humans; Incidence; Lumbar Vertebrae; Osteocalcin; Osteoporosis; Radionuclide Imaging; Treatment Outcome; Vitamin K; Vitamin K 2 | 2000 |
[Effect of vitamin K2 and estrogen administration on bone formation].
Topics: Amino Acids; Biomarkers; Bone Density; Bone Resorption; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Menopause; Osteocalcin; Osteogenesis; Osteoporosis; Treatment Outcome; Vitamin K 2 | 2004 |
Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
Topics: Alkaline Phosphatase; Amino Acids; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cholecalciferol; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Vitamin K 2 | 2006 |
4 other study(ies) available for deoxypyridinoline and menaquinone 6
| Article | Year |
|---|---|
Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long-term tail suspension.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Bone and Bones; Bone Density; Femur; Hindlimb Suspension; Rats; Rats, Sprague-Dawley; Tibia; Tomography, X-Ray Computed; Vitamin K 2; Weightlessness | 2002 |
Shift of serum osteocalcin components between cord blood and blood at day 5 of life.
Topics: Adult; Amino Acids; Bone and Bones; Fetal Blood; Humans; Immunoradiometric Assay; Infant, Newborn; Osteocalcin; Protein Processing, Post-Translational; Vitamin K; Vitamin K 1; Vitamin K 2 | 2002 |
Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Bone Density; Bone Resorption; Diphosphonates; Drug Therapy, Combination; Femur; Hindlimb Suspension; Male; Rats; Rats, Sprague-Dawley; Tail; Tibia; Tomography, X-Ray Computed; Vitamin K 2 | 2003 |
Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Matrix; Etidronic Acid; Female; Femur; Lumbar Vertebrae; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Tomography, X-Ray Computed; Vitamin K 2 | 2004 |